The purpose of this study is to evaluate the interest of breath holding for the prevention of radiation pneumonitis following conformal radiation therapy. Eligible patients will be randomly assigned in a 2-arm trial to free breathing or breath holding during conformal radiation. The primary objective of the study is to establish the efficacy of breath holding, compared to free breathing, in the prevention of early pulmonary toxicity following conformal radiation. Several departments of radiotherapy, many pneumology units and two basic and applied research laboratories take part in this multicentric study. The number of patients required to demonstrate a reduction in radiation pneumonitis from 45 % to 22.5 %, assuming an alpha risk of 5% in a two-sided test and 95% power, is 240 (120 per arm). With a planned accrual of 7 patients per month, it is estimated that the inclusion period should be approximately 3 years.
The secondary objectives are: * Validation of the Lent-Soma toxicity scale by comparison to the RTOG scale, * Response rate at different times: week 6-8, 1 year and 2 years after the end of irradiation, * Progression-free survival rate at 1 year and 2 years after the end of irradiation * Confirmation of the predictive value of serum cytokine levels (IL-6 and IL-10) during irradiation for the occurrence of early radiation toxicity, and analysis of the correlation between these serum levels at inclusion and the expression polymorphism of candidate genes.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Enrollment
242
Free breathing during conformal radiation
Breath holding during conformal radiation
Centre Oscar Lambret
Lille, France
Centre Léon Bérard
Lyon, France
Institut Curie
Paris, France
Hôpital de la Pitié Salpêtrière
Paris, France
Hôpital Européen Georges Pompidou
Paris, France
Centre Catalan d'Oncologie
Perpignan, France
Centre René Gauducheau
Saint-Herblain, France
Clinical, functional and radiological evaluations at 6-8 weeks and 10-12 weeks after the end of irradiation
Time frame: 6-8 and 10-12 weeks after the end of irradiation
RTOG and LENT-SOMA scores at 6-8 weeks and 10-12 weeks after the end of irradiation, response rates at 6-8 weeks, 1 year and 2 years after irradiation
Time frame: 6-8 and 10-12 weeks after the end of irradiation
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.